聯(lián)系電話
上海允麥生物科技有限公司
中級(jí)會(huì)員·7年
- 聯(lián)系人：
- 麥經(jīng)理
- 電話：
- 86-021-34553900
- 手機(jī)：
- 15121004110
- 傳真：
- 86-021-34553900
- 地址：
- 上海市青浦區(qū)
- 個(gè)性化：
- www.shymbio.com
- 網(wǎng)址：
- www.shymbio.com
掃一掃訪問(wèn)手機(jī)商鋪
Recombinant human VEGF-A
Vascuoar endothelial growth factor A; VEGF A; vascular endothelial growth factor A isoform 2 precursor; MGC70609; MVCD1; VEGF; VPF; VEGFA_HUMAN; VEGF-A; Vascular permeability factor (VPF);
濃度：1mg/ ml
來(lái)源：Recombinant Human
純度：≥95% SDS-PAGE
表達(dá)系統(tǒng)：HEK 293 cells
標(biāo)簽：His tag
蛋白長(zhǎng)度：Full length protein
內(nèi)毒素水平：<1.000 Eu/µg
純化方法：HPLC
應(yīng)用：SDS-PAGE，Western blot，ELISA
Biological activity,immunology research
保存：-20℃
保質(zhì)期：1年
產(chǎn)品名稱(chēng)：Rabbit Anti-VEGF-A antibody
Rabbit Anti-VEGF-A
別名：Vascuoar endothelial growth factor A; VEGF A; vascular endothelial growth factor A isoform 2 precursor; MGC70609; MVCD1; VEGF; VPF; VEGFA_HUMAN; VEGF-A; Vascular permeability factor (VPF);
來(lái)源：Rabbit
克隆類(lèi)型：Polyclonal
濃度：1mg/ml
亞型：IgG
應(yīng)用： WB=1:1000-1:2000,Elisa=1:1000-1:2000,IHC-P=1:100-500,IHC-F=1:100-500,ICC/IF=1:100-500,IF=1:100-500
反應(yīng)：Human,Mouse,Rat,Rabbit (predicted: Pig,Cow,Chicken,Dog)
理論分子量：24kDa
免疫原：KLH conjugated synthetic peptide derived from human VEGF-A
保存：-20℃
保質(zhì)期：1年
單克隆抗體
產(chǎn)品名稱(chēng)：Anti-VEGF-A antibody
Mouse Anti-VEGF-A
別名：Vascuoar endothelial growth factor A; VEGF A; vascular endothelial growth factor A isoform 2 precursor; MGC70609; MVCD1; VEGF; VPF; VEGFA_HUMAN; VEGF-A; Vascular permeability factor (VPF);
來(lái)源：Mouse
克隆類(lèi)型：Monoclonal
濃度：1mg/ml
亞型：IgG
應(yīng)用： WB=1:1000-1:2000,Elisa=1:1000-1:2000,IHC-P=1:100-500,IHC-F=1:100-500,ICC/IF=1:100-500,IF=1:100-500
反應(yīng): Human
理論分子量：24kDa
免疫原：KLH conjugated synthetic peptide derived from human VEGF-A
保存：-20℃
保質(zhì)期：1年
This gene is a member of the PDGF/VEGF growth factor family and encodes a protein that is often found as a disulfide linked homodimer. This protein is a glycosylated mitogen that specifically acts on endothelial cells and has various effects, including mediating increased vascular permeability, inducing angiogenesis, vasculogenesis and endothelial cell growth, promoting cell migration, and inhibiting apoptosis. Elevated levels of this protein is linked to POEMS syndrome, also known as Crow-Fukase syndrome. Mutations in this gene have been associated with proliferative and nonproliferative diabetic retinopathy. Alternatively spliced transcript variants, encoding either freely secreted or cell-associated isoforms, have been characterized. There is also evidence for the use of non-AUG (CUG) translation initiation sites upstream of, and in-frame with the first AUG, leading to additional isoforms.
